Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

被引：0
|
作者：
R. Mercieca-Bebber
E. H. Barnes
K. Wilson
Z. Samoon
E. Walpole
T. Mai
S. Ackland
M. Burge
G. Dickie
D. Watson
J. Leung
T. Wang
R. Bohmer
D. Cameron
J. Simes
V. Gebski
M. Smithers
J. Thomas
J. Zalcberg
A. P. Barbour
机构：
[1] University of Sydney,National Health and Medical Research Council (NHMRC) Clinical Trials Centre, Faculty of Medicine and Health
[2] Princess Alexandra Hospital,Division of Cancer Services
[3] University of Queensland,School of Clinical Medicine
[4] The University of Queensland,Faculty of Medicine
[5] University of Newcastle,School of Medicine and Public Health
[6] Royal Brisbane and Women’s Hospital,Cancer Care Services
[7] Flinders University,Discipline of Surgery, College of Medicine and Public Health
[8] GenesisCare St Andrew’s Hospital,Crown Princess Mary Cancer Center, Westmead hospital; Faculty of Medicine and Health
[9] University of Sydney,School of Public Health and Preventive Medicine
[10] Hobart Private Hospital,undefined
[11] Townsville University Hospital,undefined
[12] Divisions of Surgery and Cancer Services,undefined
[13] Princess Alexandra Hospital,undefined
[14] GIAST Clinic Mater Medical Centre South Brisbane,undefined
[15] Monash University,undefined
来源：
BMC Cancer | / 22卷
关键词：
Oesophageal adenocarcinoma; Gastro-oesophageal adenocarcinoma; Neoadjuvant therapy; Quality of life; Patient-reported outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] PATIENT-REPORTED OUTCOMES FOLLOWING DISCONTINUATION OF METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB: RESULTS FROM A RANDOMISED CONTROLLED TRIAL
    Kremer, J.
    Rigby, W.
    Singer, N.
    Birchwood, C.
    Gill, D.
    Reiss, W.
    Best, J.
    Pei, J.
    Michalska, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1386 - 1387
  • [42] The effectiveness of providing peer benchmarked feedback to hip replacement surgeons based on patient-reported outcome measures-results from the PROFILE (Patient-Reported Outcomes: Feedback Interpretation and Learning Experiment) trial: a cluster randomised controlled study
    Boyce, Maria B.
    Browne, John P.
    BMJ OPEN, 2015, 5 (07):
  • [43] Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial
    Bachert, Claus
    Hellings, Peter
    Mullol, Joaquim
    Hamilos, Daniel
    Naclerio, Robert
    Joish, Vijay N.
    Mannent, Leda
    Evans, Robert E.
    Grabher, Annette
    Abbe, Adeline
    Amand, Caroline
    Taniou, Christine
    Zhang, Donghui
    Fan, Chunpeng
    Pirozzi, Gianluca
    Graham, Neil
    Mastey, Vera
    Mahajan, Puneet
    Staudinger, Heribert
    Eckert, Laurent
    Khan, Asif
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [44] Estimation of the Harvey Bradshaw Index from the Patient-Reported Outcome 2 in Crohn's Disease: Results Based on a Large Scale Randomized Controlled Trial
    Khanna, Reena
    Son, Surim
    Zou, Guangyong
    Roshanov, Pavel S.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [45] Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial
    Lipton, Richard B.
    Harriott, Andrea
    Ma, Julia
    Smith, Jonathan H.
    Severt, Lawrence
    Stokes, Jonathan
    Gandhi, Pranav
    Parikh, Krutika
    Trugman, Joel M.
    Dodick, David W.
    CEPHALALGIA, 2023, 43 (1supp) : 62 - 63
  • [46] Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial
    Chen, Ronald C.
    Zhang, Yuanye
    Chen, Ming-Hui
    McMahon, Elizabeth
    Loffredo, Marian
    McPherson, Carol P.
    Nguyen, Angela U.
    Nguyen, Paul L.
    D'Amico, Anthony V.
    BJU INTERNATIONAL, 2012, 110 (11) : 1690 - 1695
  • [47] Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial
    Lipton, Richard B.
    Harriott, Andrea
    Ma, Julia
    Smith, Jonathan H.
    Severt, Lawrence
    Stokes, Jonathan
    Gandhi, Pranav
    Parikh, Krutika
    Trugman, Joel M.
    Dodick, David W.
    NEUROLOGY, 2023, 100 (17)
  • [48] Results of a pilot feasibility randomised controlled trial exploring the use of an electronic patient-reported outcome measure in the management of UK patients with advanced chronic kidney disease
    Kyte, Derek
    Anderson, Nicola
    Bishop, Jon
    Bissell, Andrew
    Brettell, Elizabeth
    Calvert, Melanie
    Chadburn, Marie
    Cockwell, Paul
    Dutton, Mary
    Eddington, Helen
    Forster, Elliot
    Hadley, Gabby
    Ives, Natalie J.
    Jackson, Louise J.
    O'Brien, Sonia
    Price, Gary
    Sharpe, Keeley
    Stringer, Stephanie
    Verdi, Rav
    Waters, Judi
    Wilcockson, Adrian
    BMJ OPEN, 2022, 12 (03):
  • [49] Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial (vol 4, pg 963, 2018)
    Murphy, J. E.
    Wo, J. Y.
    Ryan, D. P.
    JAMA ONCOLOGY, 2018, 4 (10) : 1439 - 1439
  • [50] Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer
    Kawahara, Takuya
    Shimozuma, Kojiro
    Shiroiwa, Takeru
    Hagiwara, Yasuhiro
    Uemura, Yukari
    Watanabe, Takanori
    Taira, Naruto
    Fukuda, Takashi
    Ohashi, Yasuo
    Mukai, Hirofumi
    ONCOLOGY, 2018, 94 (02) : 107 - 115
12345